As described previously [36], each Stealth siRNA that targeted supervillin splice isoforms (SV1, SV4, and SV5) in HCC cells reduced the level of each isoform by ≥75% (Additional file 1: Figure S1A-C). This evidence concerns the gene SVIL and hepatocellular carcinoma.